Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia


ABSTRACT: Fusion proteins involving the ETS factor ERG have been associated with multiple cancers such as Ewing's sarcoma and prostate cancer. In acute myeloid leukemias harboring t(16;21) another ERG fusion protein is expressed, FUS-ERG. Here, we found that this FUS-ERG oncofusion protein acts in the context of a heptad of proteins (ERG, FLI1, GATA2, LYL1, LNMO2, RUNX1 and TAL1) central to proper expression of genes involved in maintaining a stem cell hematopoietic phenotype. Moreover, in t(16;21) FUS-ERG co-occupies genomic regions bound by the nuclear receptor heterodimer RXR-RARA inhibiting target gene expression and interfering with hematopoietic differentiation. All-Trans Retinoic Acid treatment of t(16;21) cells as well as FUS-ERG knock down alleviate the myeloid differentiation block. Together, the results suggest that FUS-ERG acts as a transcriptional repressor of the retinoic acid signaling pathway. Cell lines were used for RNA extraction for RNA-seq and ChIP experiments for ChIP-seq.

ORGANISM(S): Homo sapiens

SUBMITTER: Joost Martens 

PROVIDER: E-GEOD-60477 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2011-11-30 | E-GEOD-32481 | biostudies-arrayexpress
2018-07-25 | PXD009760 | Pride
2021-03-05 | E-MTAB-9211 | biostudies-arrayexpress
2010-08-25 | E-GEOD-16671 | biostudies-arrayexpress
2013-01-25 | E-GEOD-43308 | biostudies-arrayexpress
2013-12-16 | E-GEOD-50178 | biostudies-arrayexpress
2016-07-05 | E-GEOD-77704 | biostudies-arrayexpress
2023-03-22 | PXD036882 | Pride
2016-06-13 | E-GEOD-71812 | biostudies-arrayexpress
2012-07-23 | E-GEOD-36153 | biostudies-arrayexpress